Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filedlitigationCriticalhttps://patents.darts-ip.com/?family=40161347&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY31185(A1)"Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham CorpfiledCriticalSmithkline Beecham Corp
Publication of UY31185A1publicationCriticalpatent/UY31185A1/en
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K31/00—Medicinal preparations containing organic active ingredients
A61K31/33—Heterocyclic compounds
A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
A61K31/4965—Non-condensed pyrazines
A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
Landscapes
Health & Medical Sciences
(AREA)
Chemical & Material Sciences
(AREA)
Medicinal Chemistry
(AREA)
Pharmacology & Pharmacy
(AREA)
Epidemiology
(AREA)
Life Sciences & Earth Sciences
(AREA)
Animal Behavior & Ethology
(AREA)
General Health & Medical Sciences
(AREA)
Public Health
(AREA)
Veterinary Medicine
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Plural Heterocyclic Compounds
(AREA)
Abstract
Se proporcionan métodos para el tratamiento de tumores del sistema nervioso central primarios o secundarios en un mamífero, en donde los métodos comprenden la administración de un compuesto de tiofeno de bencimidazole.Methods are provided for the treatment of primary or secondary central nervous system tumors in a mammal, wherein the methods comprise the administration of a benzimidazole thiophene compound.
UY31185A2007-06-272008-06-26
METHODS FOR TUMOR TREATMENT IN THE NERVOUS SYSTEM
UY31185A1
(en)
Substituted amino- (pyridine-4-carboxylic acid) derivative compounds, histone demethylase inhibitors; pharmaceutical composition, comprising them, useful in the treatment of cancer, such as prostate, breast, bladder, lung and / or melanoma cancer.
Compounds derived from indazol-3-carboxamides, as inhibitors of the wnt / b-catenin signaling pathway; pharmaceutical composition that includes them; and its use for the treatment of cancer, rheumatoid arthritis, fungal and viral infections, parkinson's disease, a fibrotic disorder, among other diseases.
Compounds derived from benzimidazole substituted with a substituted pyrazole group, kinase inhibitor fgfr; pharmaceutical composition comprising them; and its use in the treatment of cancer.
Compounds derived from triazolopyridine, such as ttk inhibitors; method of preparing said compounds; pharmaceutical composition and combination that includes them; and its use for the prophylaxis or treatment of a hematological tumor, a solid tumor and / or its metastases, gastrointestinal tumors, urinary tract tumors, mammary tumors and other gynecological tumors, among others.
Compounds derived from substituted pyrrolidine-2-carboxamides; mdm2-p53 interaction inhibitors; pharmaceutical composition; and its use for the treatment of cancer, particularly solid tumors.
Compound derived from substituted pyrazolopyridine, lrrk2 kinase inhibitor; process of preparing said compound; pharmaceutical composition; pharmaceutical combination; use of the compound to prevent or treat a disorder selected from cancer and neurodegenerative diseases.
Pharmaceutical combinations comprising an antibody that specifically recognizes cd38 and at least vincristine; and use of the antibody that specifically recognizes cd38 for the treatment of cancer.